NRIX P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
NRIX's p/e ratio is higher than 95% of the last 10 years.
P/E ratio History
NRIX P/E ratio by year
Yearly range of NRIX’s p/e ratio from 2020 to 2026. Over the full period it ranged from -25.4 to 11.8, averaging -6.7.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | -8.1 | -2.4 | 11.8 | 11.7 |
| 2025 | -7.1 | -4.6 | -2.8 | -6.2 |
| 2024 | -9.7 | -6.4 | -3.1 | -6.5 |
| 2023 | -4.3 | -3.1 | -1.7 | -4.1 |
| 2022 | -10.9 | -4.4 | -2.6 | -3.1 |
| 2021 | -25.3 | -13.9 | -8.0 | -10.6 |
| 2020 | -25.4 | -16.3 | -10.8 | -16.6 |
Get notified when NRIX P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is NRIX P/E ratio High or Low Right Now?
Nurix Therapeutics, Inc.'s P/E ratio is currently 11.7, which is near historic high relative to its 10-year historical range. The 10-year median P/E ratio for NRIX is approximately -5.2. See all NRIX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.